Graft loss censored for death · kidney transplant recipients: first rejection episode
Antibody (T cell) showed no clear difference in graft loss censored for death compared with steroid (stratified by antibody type) (low certainty).
1 finding from 1 review
Death · kidney transplant recipients: first rejection episode
It is very uncertain whether antibody (T cell) changes death compared with steroid (stratified by antibody type) (very low certainty).
1 finding from 1 review
Treatment adverse events: fever, chills, malaise after drug administration · kidney transplant recipients: first rejection episode
It is very uncertain whether antibody (T cell) changes treatment adverse events: fever, chill, or malaise after drug… compared with steroid (stratified by antibody type) (very low certainty).
1 finding from 1 review
Failure of acute rejection reversal · kidney transplant recipients: first rejection episode
Antibody (T cell) + steroid showed no clear difference in failure of reversal of acute rejection episode compared with steroid alone (low certainty).
1 finding from 1 review
Recurrent rejection · kidney transplant recipients: first rejection episode
Antibody (T cell) + steroid showed no clear difference in recurrent rejection compared with steroid alone (low certainty).
1 finding from 1 review
Graft loss or death with a functioning graft · kidney transplant recipients: first rejection episode
It is very uncertain whether antibody (T cell) + steroid changes graft loss or death with a functioning graft compared with steroid alone (very low certainty).
1 finding from 1 review
Intervention not reported
Death (including CNI) · kidney transplant recipients
The intervention showed no clear difference in death (including CNI) (low certainty).
1 finding from 1 review
Intervention not reported
Biopsy‐proven CAN (ESW with alemtuzumab only) · kidney transplant recipients
The intervention may leads to higher biopsy‐proven CAN (ESW with alemtuzumab only) (low certainty).
1 finding from 1 review
Intervention not reported
CMV infection (all studies) · kidney transplant recipients
The intervention showed no clear difference in CMV infection (all studies) (low certainty).
1 finding from 1 review
Intervention not reported
NODAT (ESW alemtuzumab only) · kidney transplant recipients
The intervention showed no clear difference in NODAT (ESW alemtuzumab only) (low certainty).
1 finding from 1 review
Intervention not reported
Malignancy (all studies) · kidney transplant recipients
It is very uncertain whether the intervention changes malignancy (all studies) (very low certainty).
1 finding from 1 review
Intervention not reported
All‐cause graft loss (including CNI) · kidney transplant recipients
The intervention showed no clear difference in all‐cause graft loss (including CNI) (low certainty).
1 finding from 1 review
Intervention not reported
Delayed graft function · kidney transplant recipients
The intervention showed no clear difference in delayed graft function (low certainty).
1 finding from 1 review
Intervention not reported
Acute rejection (including CNI) · kidney transplant recipients
The intervention probably leads to lower acute rejection (including CNI) (moderate certainty).
1 finding from 1 review
Intervention not reported
Infection: CMV infection · kidney transplant recipients
The intervention probably leads to higher infection: CMV infection (moderate certainty).
1 finding from 1 review
Intervention not reported
Malignancy · kidney transplant recipients
The intervention showed no clear difference in malignancy (low certainty).
1 finding from 1 review
Intervention not reported
Death (ESW both arms) · kidney transplant recipients
The intervention showed no clear difference in death (ESW both arms) (low certainty).
1 finding from 1 review
Intervention not reported
All‐cause graft loss (ESW both arms) · kidney transplant recipients
The intervention showed no clear difference in all‐cause graft loss (ESW both arms) (low certainty).
1 finding from 1 review
Intervention not reported
Acute rejection (ESW both arms) · kidney transplant recipients
The intervention probably leads to lower acute rejection (ESW both arms) (moderate certainty).
1 finding from 1 review